Changes in prescribing behaviors after implementing drug reimbursement rate reduction policy in Taiwan: Implications for the medicare system

Journal of Health Care Finance

Volumn 34, Issue 3, 2007, Pages 45-54

  Chu, Hsuan Lien ^a   Liu, Shuen Zen ^b   Romeis, James C ^c  

^a NATIONAL TAIPEI UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Drug reimbursement rate reduction; National Health Insurance; Physician financial incentives

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; HEALTH CARE POLICY; HEALTH PERSONNEL ATTITUDE; HUMAN; MAJOR CLINICAL STUDY; MEDICARE; PRESCRIPTION; REIMBURSEMENT; TAIWAN;

HUMANS; NATIONAL HEALTH PROGRAMS; PHYSICIAN'S PRACTICE PATTERNS; POLICY MAKING; PRESCRIPTIONS, DRUG; REIMBURSEMENT MECHANISMS; TAIWAN;

EID: 40649091644     PISSN: 10786767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. B.L. Walser, D.R. Degnan, and S.B. Soumerai, "Do Open Formularies Increase Access to Clinically Useful Drugs?" Health Affairs (1996), 15: 95-109;
2. H.L. Lipton, D.J. Gross, M.R. Stebbins, and L.H. Syed, "Managing the Pharmacy Benefit in Medicare HMOs: What Do We Really Know?" Health Affairs (2000), 19(2): 42-57;
3. S. Levine, D. Campen, M. Millares, and A. Barrueta, "Kaiser Permanente's Prescription Drug Benefit," Health Affairs (2000), 19(2): 185-190;
4. J.L. Bastida and E. Mossialos, "Pharmaceutical expenditure in Spain: Cost and Control," International Journal of Health Services (2000), 30(3): 597-616.
5. D. Menon, "Pharmaceutical Cost Control in Canada: Does It Work?" Health Affairs (2001), 20(3): 92-103.
6. J.K. Iglehart, "Medicare and Drug Pricing," New England Journal of Medicine (2003), 348(16): 1590-1597.
7. R. Abelson, "Drug Sales Bring Huge Profits, and Scrutiny, to Cancer Doctors," New York Times (Jan. 2003), 26.
8. T.M. Cheng, "Taiwan's New National Health Insurance Program: Genesis and Experience so Far," Health Affairs (2003), 22(3): 61-76.
9. J.C. Lo, "Patients' Attitudes vs. Physicians' Determination: Implications for Cesarean Sections," Social Science Medicine (2003), 57: 91-96.
10. H.L. Chu, S.Z. Liu, and J.C. Romeis, "The Initial Effects of Physician Compensation Programs in Taiwan Hospitals: Implications for Staff Model HMOs," Health Care Management Science (2003), 6(1): 17-26;
11. T.M. Cheng, "Taiwan's New National Health Insurance Program: Genesis and Experience so Far," Health Affairs (2003), 22(3): 61-76;
12. H.L. Chu, S.Z. Liu, C.L. Yaung, and J.C. Romeis, "Does the Implementation of Responsibility Centers, Total Quality Management, and Physician Fee Programs Improve Hospital Efficiency - Evidence from Taiwan Hospitals," Medical Care (2002) 40(12): 1233-1237.
13. B.L. Landon, J.D. Reschovsky, and D. Blumenthal, "Physicians' Views of Formularies: Implications for Medicare Drug Benefit Design," Health Affairs (2004), 23(1): 218.
14. T.M. Cheng, "Taiwan's New National Health Insurance Program: Genesis and Experience so Far," Health Affairs (2003), 22(3): 61-76.
15. S.Z. Liu and J.C. Romeis, "Assessing the Effect of Taiwan's Outpatient Prescription Drug Co-Payment Policy in the Elderly," Medical Care (2003), 41(12): 1331-1342.
16. C.T. Horngren, S.M. Datar, and G. Foster, Cost Accounting - A Managerial Emphasis (2006), 12th ed., pp. 210-221, Upper Saddle River, NJ: Prentice Hall.
17. S.Z. Liu and J.C. Romeis, "Assessing the Effect of Taiwan's Outpatient Prescription Drug Co-Payment Policy in the Elderly," Medical Care (2003), 41(12): 1331-1342.
18. Id.